VANDELLI, Maria Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 38.100
EU - Europa 22.423
AS - Asia 17.813
SA - Sud America 2.429
AF - Africa 445
OC - Oceania 70
Continente sconosciuto - Info sul continente non disponibili 30
Totale 81.310
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.560
GB - Regno Unito 6.108
SE - Svezia 5.394
SG - Singapore 5.126
CN - Cina 5.106
IT - Italia 4.936
HK - Hong Kong 2.279
VN - Vietnam 1.840
BR - Brasile 1.802
DE - Germania 1.206
FI - Finlandia 829
TR - Turchia 811
UA - Ucraina 784
RU - Federazione Russa 774
FR - Francia 706
KR - Corea 618
IN - India 467
BG - Bulgaria 306
NL - Olanda 253
CA - Canada 247
AR - Argentina 205
BD - Bangladesh 190
ID - Indonesia 187
JP - Giappone 182
IQ - Iraq 168
MX - Messico 163
ZA - Sudafrica 148
IE - Irlanda 143
ES - Italia 129
PK - Pakistan 124
RO - Romania 124
PL - Polonia 120
EC - Ecuador 109
BE - Belgio 107
AE - Emirati Arabi Uniti 102
CO - Colombia 95
CH - Svizzera 76
LT - Lituania 65
AU - Australia 61
MY - Malesia 61
VE - Venezuela 61
IR - Iran 56
AT - Austria 55
CL - Cile 55
MA - Marocco 55
PH - Filippine 55
CZ - Repubblica Ceca 53
EG - Egitto 51
UZ - Uzbekistan 51
SA - Arabia Saudita 46
IL - Israele 43
TN - Tunisia 43
DZ - Algeria 37
LU - Lussemburgo 37
PY - Paraguay 36
PE - Perù 34
PT - Portogallo 34
TW - Taiwan 33
NP - Nepal 32
JO - Giordania 31
TH - Thailandia 31
KE - Kenya 29
GR - Grecia 27
JM - Giamaica 25
EU - Europa 23
AZ - Azerbaigian 21
KZ - Kazakistan 20
DK - Danimarca 18
ET - Etiopia 18
DO - Repubblica Dominicana 17
MD - Moldavia 17
UY - Uruguay 17
AL - Albania 16
HU - Ungheria 16
TT - Trinidad e Tobago 15
BO - Bolivia 14
CR - Costa Rica 14
LB - Libano 14
OM - Oman 14
RS - Serbia 14
SN - Senegal 14
KG - Kirghizistan 12
BY - Bielorussia 11
NO - Norvegia 11
PA - Panama 10
SI - Slovenia 10
CY - Cipro 9
EE - Estonia 9
NZ - Nuova Zelanda 9
BH - Bahrain 8
GT - Guatemala 8
HR - Croazia 8
NI - Nicaragua 8
AM - Armenia 7
KH - Cambogia 7
LA - Repubblica Popolare Democratica del Laos 7
LV - Lettonia 7
LY - Libia 7
PR - Porto Rico 7
PS - Palestinian Territory 7
Totale 81.165
Salva come PNG Salva come JPEG
Città #
Southend 4.606
Stockholm 3.593
Ashburn 3.529
Santa Clara 3.464
Singapore 3.198
Fairfield 2.822
Hong Kong 2.236
Chandler 2.167
Woodbridge 2.027
Hefei 1.714
Chicago 1.546
Jacksonville 1.534
Houston 1.411
San Jose 1.215
Seattle 1.199
Wilmington 1.171
Dearborn 1.131
Ann Arbor 1.073
Nyköping 1.028
Beijing 958
Cambridge 955
Los Angeles 874
London 783
Modena 645
Ho Chi Minh City 607
Seoul 529
Helsinki 521
Council Bluffs 462
Izmir 461
The Dalles 458
Hanoi 426
Salt Lake City 394
New York 382
Milan 331
Princeton 313
Sofia 291
Dallas 273
San Diego 267
Eugene 265
Lauterbourg 254
Rome 229
Buffalo 222
Bologna 210
Moscow 202
Des Moines 190
Redwood City 185
Shanghai 185
São Paulo 172
Elk Grove Village 165
Tampa 165
Munich 160
Orem 141
Tokyo 133
Frankfurt am Main 127
Bremen 124
Jakarta 117
Fremont 113
Dublin 112
Columbus 98
Reggio Emilia 95
Brussels 92
Phoenix 92
Chennai 91
Lancaster 90
Guangzhou 86
Boardman 83
Falls Church 81
Miami 79
Sterling 75
Johannesburg 73
Da Nang 71
Warsaw 71
Naples 70
Haiphong 69
Atlanta 65
Parma 65
Amsterdam 58
Baghdad 58
Washington 55
Montreal 54
Brooklyn 53
Como 53
Denver 53
Dulles 53
Nanjing 53
Turku 49
Detroit 48
Norwalk 48
Toronto 48
Mexico City 47
Mumbai 47
Turin 47
Kent 46
Florence 44
Tashkent 44
Bari 42
Kunming 42
Rio de Janeiro 42
Catania 41
Guayaquil 40
Totale 56.676
Salva come PNG Salva come JPEG
Nome #
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 2.291
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.028
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 573
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 502
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 488
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 465
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 456
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 454
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 451
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 451
The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions 448
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 434
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 432
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 426
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 426
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 424
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 420
Cationic liposomes for gene transfection 419
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 413
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 412
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 411
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 411
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 408
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 399
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 398
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 394
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 393
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 388
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 386
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 381
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 380
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method 373
A Metabolomic Approach Applied to a LiquidChromatography Coupled to High-ResolutionTandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the ComprehensiveEvaluation of the Chemical Composition ofCannabis Medicinal Extracts 373
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 371
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 364
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 364
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 364
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 362
Polymeric nanoparticles for the drug delivery to the central nervous system 361
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 360
Distribution of drugs in polymers loaded by swelling 358
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 356
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 354
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 352
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 347
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 347
Brain targeting with polymeric nanoparticles: which administration route should we take? 346
Protein corona and nanoparticles: How can we investigate on? 346
Microwave-treated gelatin microspheres as drug delivery system 342
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 342
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 342
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 341
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Bead coating process via an excess of crosslinking agent 339
Nanoparticle transport across the blood brain barrier 338
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 338
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 337
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 329
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 328
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 328
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 327
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 325
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 324
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 323
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 323
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 322
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 321
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 320
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 319
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 317
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 317
Pharmaceutical and biomedical analysis of cannabinoids: A critical review 314
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 313
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 313
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 312
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 311
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 310
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 306
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 305
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 304
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 303
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 302
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 301
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 301
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 300
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 300
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 300
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 299
Functionalization of liposomes: microscopical methods for preformulative screening 299
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 299
Colloidal systems for CNS drug delivery 297
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 297
Properties of tolmetin-loaded Eudragit RL100 and Eudragit RS100 microparticles prepared by different techniques 296
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 296
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 296
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 295
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 293
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 292
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 292
Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence 291
Totale 39.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 289.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 289.870
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021824 0 0 0 0 0 0 0 0 0 0 454 370
2021/20225.454 242 633 533 395 201 251 288 344 626 403 891 647
2022/20236.359 751 688 500 621 732 933 171 561 734 117 244 307
2023/20244.469 224 264 273 353 912 463 524 576 161 139 209 371
2024/202513.981 758 200 301 1.052 2.683 1.898 1.053 923 1.353 529 1.477 1.754
2025/202627.699 1.679 978 2.015 3.195 4.773 1.796 2.808 1.298 6.270 2.407 480 0
Totale 81.800